InvestorsHub Logo
Followers 484
Posts 60890
Boards Moderated 18
Alias Born 09/20/2001

Re: plexrec post# 455924

Friday, 04/05/2024 4:40:24 PM

Friday, April 05, 2024 4:40:24 PM

Post# of 462551
OK - correct me if I'm wrong...

The Aussies have data on Parkinson's and Alzheimer's.

There is Rett Syndrome data from the U.S. and Australia, but they are applying for EMA approval based on unique criteria in that jurisdiction..

https://www.nasdaq.com/articles/anavex-avxl-up-12-on-regulatory-update-for-alzheimers-drug

PLEASE DON'T DISS this post. Correct and add DD, but all purely negative criticism will be ignored.

I am looking to build a correct and succinct statement of Blarcamesine' s position in the regulatory matrix.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News